Zomedica Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Zomedica Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2024.
  • Zomedica Corp. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$23.9M, a 356% decline year-over-year.
  • Zomedica Corp. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$27.8M, a 43.2% decline year-over-year.
  • Zomedica Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.39M, a 62.5% increase from 2022.
  • Zomedica Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$17M, a 7.45% increase from 2021.
  • Zomedica Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$18.4M, a 8.71% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$27.8M -$23.9M -$18.7M -356% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$9.16M -$9.16M -$2.78M -43.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$6.39M $5.74M +$8.55M Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$14.9M -$491K +$4.5M +90.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$19.4M -$5.25M +$24K +0.46% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$19.5M -$6.39M -$2.45M -62.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$17M -$2.81M +$480K +14.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$17.5M -$5M +$1.35M +21.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$18.8M -$5.27M -$562K -11.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$18.3M -$3.94M +$100K +2.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$18.4M -$3.29M +$883K +21.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$19.3M -$6.35M -$1.37M -27.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$17.9M -$4.71M +$597K +11.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$18.5M -$4.04M -$1.59M -64.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$16.9M -$4.17M -$1.32M -46.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$15.6M -$4.98M -$2.13M -75% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$13.5M -$5.31M -$2.9M -121% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$10.6M -$2.45M +$9.23M +79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$19.8M -$2.86M +$5.56M +66.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$25.3M -$2.85M -$935K -49% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$24.4M -$2.4M +$1.74M +42% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$26.2M -$11.7M -$9.51M -438% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$16.6M -$8.42M -$5.86M -229% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$10.8M -$1.91M +$170K +8.19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$11M -$4.14M -$2.56M -161% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$8.4M -$2.17M -$339K -18.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$8.07M -$2.56M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-14
Q3 2017 -$2.08M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$1.59M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.83M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.